Alternative medicine
fromwww.nytimes.com
1 month agoPatients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
FDA's crackdown on cheap weight-loss drugs threatens access for many Americans, raising treatment costs.
Compounded versions of Wegovy and Zepbound to be phased out as shortages are declared over.